谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Comparison Between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings.

Hideko Ohama,Atsushi Hiraoka,Toshifumi Tada,Masashi Hirooka,Kazuya Kariyama,Joji Tani,Masanori Atsukawa,Koichi Takaguchi,Ei Itobayashi,Shinya Fukunishi,Kunihiko Tsuji,Toru Ishikawa,Kazuto Tajiri,Hironori Ochi,Satoshi Yasuda,Hidenori Toyoda,Chikara Ogawa,Takashi Nishimura,Takeshi Hatanaka,Satoru Kakizaki,Noritomo Shimada,Kazuhito Kawata,Atsushi Naganuma,Hisashi Kosaka,Tomomitsu Matono,Hiroshi Shibata,Tomoko Aoki,Fujimasa Tada,Kazuhiro Nouso,Asahiro Morishita,Akemi Tsutsui,Takuya Nagano,Norio Itokawa,Tomomi Okubo,Taeang Arai,Michitaka Imai,Yohei Koizumi,Shinichiro Nakamura,Hiroko Iijima,Masaki Kaibori,Yoichi Hiasa,Masatoshi Kudo,Takashi Kumada

Oncology（2023）

引用 0|浏览59
暂无评分
关键词
Hepatocellular carcinoma,Atezolizumab Plus bevacizumab,Lenvatinib,Child-Pugh B
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要